甲状旁腺近红外自体荧光检测:炒作还是机遇?
本文综述了近红外自体荧光(NIRAF)技术用于术中识别甲状旁腺(PG)的研究,指出该技术无标记、非侵入,已获FDA批准两款设备,但现有研究多为技术可行性探索,缺乏长期结局与成本效益证据。
要点
- NIRAF可无标记实时识别甲状旁腺组织,已获FDA批准两款设备。
- 现有研究聚焦术中识别、定位、区分健康与病变PG及减少术后低钙血症。
- 需更多长期结局研究明确该技术对患者结局和成本效益的影响。
核心结论
- NIRAF用于甲状旁腺识别无标记且非侵入,技术热度上升,但需更多长期结局研究确定其对患者结局和成本效益的影响。
研究设计与样本
- 综述:在PubMed和Google Scholar以「parathyroid, near infrared, autofluorescence」等关键词检索相关文献,排除仅聚焦对比剂、评论/概述或非英文文章。
主要发现
- 研究探索了NIRAF用于术中识别PG组织、解剖前后定位PG、区分健康与病变PG以及减少全甲状腺切除术后低钙血症的潜力。
临床怎么用
- NIRAF可作为术中辅助识别和保留甲状旁腺的无标记工具,但当前设备存在局限性,需迭代改进。
局限性
- 现有研究多缺乏长期结局数据,对患者结局和实际成本效益的影响尚不明确。
- 综述排除了仅聚焦对比剂、评论/概述及非英文文献,可能遗漏部分证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: With the recent approval of 2 NIRAF-based devices for label-free identification of PG by the Food and Drug Administration, it becomes crucial to educate the surgical community on the realistic scope of this emerging technology. Here, we have compiled a review of studies that utilize NIRAF and present a critical appraisal of this technique for intraoperative PG detection. BACKGROUND: Failure to visualize PGs could lead to accidental damage/excision of healthy PGs or inability to localize diseased PGs, resulting in postsurgical complications. The discovery that PGs have NIRAF led to new avenues for intraoperatively identifying PGs with high accuracy in real-time. METHODS: Using the following key terms: "parathyroid, near infrared, autofluorescence" in various search engines such as PubMed and Google Scholar, we identified various publications relevant to this review of NIRAF as a technique for PG identification. Articles were excluded if they focused solely on contrast agents, served as commentaries/overviews on NIRAF or were not written in English. RESULTS: To date, studies have investigated the potential of NIRAF detection for (i) identifying PG tissues intraoperatively, (ii) locating PGs before or after dissection, (iii) distinguishing healthy from diseased PGs, and (iv) minimizing postoperative hypocalcemia after total thyroidectomy. CONCLUSIONS: Because NIRAF-based identification of PG is noninvasive and label-free, the popularity of this approach has considerably surged. As the present limitations of various technologies capable of NIRAF detection are identified, we anticipate that newer device iterations will continue to be developed enhancing the current merits of these modalities to aid surgeons in identifying and preserving PGs. However, more concrete and long-term outcome studies with these modalities are essential to determine the impact of this technique on patient outcome and actual cost-benefits.
引用
- Solórzano CC, Thomas G, Baregamian N, et al. Detecting the Near Infrared Autofluorescence of the Human Parathyroid: Hype or Opportunity? Ann Surg. 2020. PMID: 31804401. doi:10.1097/SLA.0000000000003700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。